Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.

<h4>Objectives</h4>Interstitial lung disease (ILD) is an extramuscular manifestation that results in increased morbidity and mortality from polymyositis (PM) and dermatomyositis (DM). The aim of this study was to systematically evaluate risk factors associated with the development of ILD...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Zhang, Guoqin Wu, Di Gao, Guijian Liu, Lin Pan, Liyan Ni, Zheng Li, Qiang Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155381&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110723101818880
author Li Zhang
Guoqin Wu
Di Gao
Guijian Liu
Lin Pan
Liyan Ni
Zheng Li
Qiang Wang
author_facet Li Zhang
Guoqin Wu
Di Gao
Guijian Liu
Lin Pan
Liyan Ni
Zheng Li
Qiang Wang
author_sort Li Zhang
collection DOAJ
description <h4>Objectives</h4>Interstitial lung disease (ILD) is an extramuscular manifestation that results in increased morbidity and mortality from polymyositis (PM) and dermatomyositis (DM). The aim of this study was to systematically evaluate risk factors associated with the development of ILD in PM/DM.<h4>Methods</h4>Observational studies were identified from searching PubMed, Medline, Embase, and the Cochrane Library. Pooled odds ratios (ORs) or standardized mean differences (SMDs) and corresponding 95% confidence intervals (CIs) were obtained for the relationships between risk factors and ILD in PM/DM using either fixed- or random-effects models, whichever were appropriate. Heterogeneity tests, sensitivity analyses, and publication bias assessments were also performed.<h4>Results</h4>Twenty-three studies were selected for a meta-analysis that included 834 patients and 1245 control subjects. Risk factors that may have increased the risk of developing ILD in PM/DM patients included older age at diagnosis (SMD, 0.35; 95% CI, 0.18-0.52; P < 0.0001), arthritis/arthralgia (OR, 3.17; 95% CI, 1.99-5.04; P < 0.00001), fever (OR, 2.31; 95% CI, 1.42-3.76; P = 0.0007), presence of anti-Jo-1 antibodies (OR, 3.34; 95% CI, 2.16-5.16; P < 0.00001), elevated erythrocyte sedimentation rate (ESR; SMD, 0.48; 95% CI, 0.32-0.64; P < 0.00001), presence of anti-MDA5 antibodies (OR, 18.26; 95% CI, 9.66-34.51; P < 0.00001), and elevated C-reactive protein level (CRP; OR, 3.50; 95% CI, 1.48-8.28; P = 0.004). Meanwhile, malignancy (OR, 0.36; 95% CI, 0.18-0.72; P = 0.004) reduced the risk of developing ILD in PM/DM patients.<h4>Conclusion</h4>Our meta-analysis results suggest that the association between PM/DM and ILD may be due to such risk factors as older age at diagnosis, arthritis/arthralgia, fever, presence of anti-Jo-1 antibodies, elevated ESR, presence of anti-MDA5 antibodies, and elevated CRP level, while malignancy was associated with a reduced risk of developing ILD. Thus, these variables may be used to guide screening processes for ILD in patients with PM/DM.
format Article
id doaj-art-733d5f7cd1fe4979b125f68b1c94dfe6
institution OA Journals
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-733d5f7cd1fe4979b125f68b1c94dfe62025-08-20T02:37:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01115e015538110.1371/journal.pone.0155381Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.Li ZhangGuoqin WuDi GaoGuijian LiuLin PanLiyan NiZheng LiQiang Wang<h4>Objectives</h4>Interstitial lung disease (ILD) is an extramuscular manifestation that results in increased morbidity and mortality from polymyositis (PM) and dermatomyositis (DM). The aim of this study was to systematically evaluate risk factors associated with the development of ILD in PM/DM.<h4>Methods</h4>Observational studies were identified from searching PubMed, Medline, Embase, and the Cochrane Library. Pooled odds ratios (ORs) or standardized mean differences (SMDs) and corresponding 95% confidence intervals (CIs) were obtained for the relationships between risk factors and ILD in PM/DM using either fixed- or random-effects models, whichever were appropriate. Heterogeneity tests, sensitivity analyses, and publication bias assessments were also performed.<h4>Results</h4>Twenty-three studies were selected for a meta-analysis that included 834 patients and 1245 control subjects. Risk factors that may have increased the risk of developing ILD in PM/DM patients included older age at diagnosis (SMD, 0.35; 95% CI, 0.18-0.52; P < 0.0001), arthritis/arthralgia (OR, 3.17; 95% CI, 1.99-5.04; P < 0.00001), fever (OR, 2.31; 95% CI, 1.42-3.76; P = 0.0007), presence of anti-Jo-1 antibodies (OR, 3.34; 95% CI, 2.16-5.16; P < 0.00001), elevated erythrocyte sedimentation rate (ESR; SMD, 0.48; 95% CI, 0.32-0.64; P < 0.00001), presence of anti-MDA5 antibodies (OR, 18.26; 95% CI, 9.66-34.51; P < 0.00001), and elevated C-reactive protein level (CRP; OR, 3.50; 95% CI, 1.48-8.28; P = 0.004). Meanwhile, malignancy (OR, 0.36; 95% CI, 0.18-0.72; P = 0.004) reduced the risk of developing ILD in PM/DM patients.<h4>Conclusion</h4>Our meta-analysis results suggest that the association between PM/DM and ILD may be due to such risk factors as older age at diagnosis, arthritis/arthralgia, fever, presence of anti-Jo-1 antibodies, elevated ESR, presence of anti-MDA5 antibodies, and elevated CRP level, while malignancy was associated with a reduced risk of developing ILD. Thus, these variables may be used to guide screening processes for ILD in patients with PM/DM.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155381&type=printable
spellingShingle Li Zhang
Guoqin Wu
Di Gao
Guijian Liu
Lin Pan
Liyan Ni
Zheng Li
Qiang Wang
Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
PLoS ONE
title Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
title_full Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
title_fullStr Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
title_full_unstemmed Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
title_short Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
title_sort factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis a systematic review and meta analysis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155381&type=printable
work_keys_str_mv AT lizhang factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT guoqinwu factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT digao factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT guijianliu factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT linpan factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT liyanni factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT zhengli factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis
AT qiangwang factorsassociatedwithinterstitiallungdiseaseinpatientswithpolymyositisanddermatomyositisasystematicreviewandmetaanalysis